Cancer Causes & Control

, Volume 14, Issue 9, pp 805–814 | Cite as

Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study

  • Martyn Plummer
  • Rolando Herrero
  • Silvia Franceschi
  • Chris J.L.M. Meijer
  • Peter Snijders
  • F. Xavier Bosch
  • Silvia de Sanjosé
  • Nubia Muñoz


Background: Smoking has long been suspected to be a risk factor for cervical cancer. However, not all previous studies have properly controlled for the effect of human papillomavirus (HPV) infection, which has now been established as a virtually necessary cause of cervical cancer. To evaluate the role of smoking as a cofactor of progression from HPV infection to cancer, we performed a pooled analysis of 10 previously published case–control studies. This analysis is part of a series of analyses of cofactors of HPV in the aetiology of cervical cancer. Methods: Data were pooled from eight case–control studies of invasive cervical carcinoma (ICC) and two of carcinoma in situ (CIS) from four continents. All studies used a similar protocol and questionnaires and included a PCR-based evaluation of HPV DNA in cytological smears or biopsy specimens. Only subjects positive for HPV DNA were included in the analysis. A total of 1463 squamous cell ICC cases were analyzed, along with 211 CIS cases, 124 adeno- or adeno-squamous ICC cases and 254 control women. Pooled odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression models controlling for sexual and non-sexual confounding factors. Results: There was an excess risk for ever smoking among HPV positive women (OR 2.17 95%CI 1.46–3.22). When results were analyzed by histological type, an excess risk was observed among cases of squamous cell carcinoma for current smokers (OR 2.30, 95%CI 1.31–4.04) and ex-smokers (OR 1.80, 95%CI 0.95–3.44). No clear pattern of association with risk was detected for adenocarcinomas, although the number of cases with this histologic type was limited. Conclusions: Smoking increases the risk of cervical cancer among HPV positive women. The results of our study are consistent with the few previously conducted studies of smoking and cervical cancer that have adequately controlled for HPV infection. Recent increasing trends of smoking among young women could have a serious impact on cervical cancer incidence in the coming years.

Cervical cancer human papillomavirus smoking 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    IARC (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, volume 64. Human Papillomaviruses. Lyon: International Agency for Research on Cancer.Google Scholar
  2. 2.
    Walboomers JM, Jacobs MV, Manos MM, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.Google Scholar
  3. 3.
    Bosch FX, Munoz N, de Sanjose S, et al. (1992) Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 52: 750-758.Google Scholar
  4. 4.
    Chaouki N, Bosch FX, Munoz N, et al. (1998) The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 75: 546-554.Google Scholar
  5. 5.
    Chichareon S, Herrero R, Munoz N, et al. (1998) Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst. 90: 50-57.Google Scholar
  6. 6.
    Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69: 114-119.Google Scholar
  7. 7.
    Munoz N, Bosch FX, de Sanjose S, et al. (1992) The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52: 743-749.Google Scholar
  8. 8.
    Ngelangel C, Munoz N, Bosch FX, et al. (1998) Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 90: 43-49.Google Scholar
  9. 9.
    Rolon PA, Smith JS, Munoz N, et al. (2000) Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 85: 486-491.Google Scholar
  10. 10.
    Santos C, Munoz N, Klug SJ, et al. (2001) HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 85: 966-971.Google Scholar
  11. 11.
    Bosch FX, Munoz N, de Sanjose S, et al. (1993) Human papillomavirus and cervical intraepithelial neoplasia grade III/ carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2: 415-422.Google Scholar
  12. 12.
    Munoz N, Bosch FX, de Sanjose S, et al. (1993) Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2: 423-431.Google Scholar
  13. 13.
    Moreno V, Bosch FX, Munoz N, et al. (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multi-centric case control study. Lancet 359: 1085-92.Google Scholar
  14. 14.
    Munoz N, Franceschi S, Bosetti C, et al. (2002) The role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359: 1093-1101.Google Scholar
  15. 15.
    Smith JS, Herrero R, Bosetti C, et al. (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94: 1604-1613.Google Scholar
  16. 16.
    Castellsague X, Bosch FX, Munoz N, et al. (2002) Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 346: 1105-1112.Google Scholar
  17. 17.
    Winkelstein Jr W. (1977) Smoking and cancer of the uterine cervix: hypothesis. Am J Epidemiol 106: 257-259.Google Scholar
  18. 18.
    Brinton LA (1990) Editorial commentary: smoking and cervical cancer-current status. Am J Epidemiol 131: 958-960.Google Scholar
  19. 19.
    Layde PM (1989) Smoking and cervical cancer: cause or coincidence? JAMA 261: 1631-1633.Google Scholar
  20. 20.
    Moreno V, Munoz N, Bosch FX, et al. (1995) Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 4: 459-467.Google Scholar
  21. 21.
    Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Molecular Diagnostics of Human Cancer. New York: Cold Spring Harbor Press, pp. 209-214.Google Scholar
  22. 22.
    Jacobs MV, de Roda Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM (1995) Group-specific differentiation between high-and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 33: 901-905.Google Scholar
  23. 23.
    Roda Husman AM, Walboomers JM, Meijer CJ, et al. (1994) Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 56: 802-806.Google Scholar
  24. 24.
    Walboomers JMM, Melkert PWJ, van den Brule AJC, Snijders PJF, Meijer CJLM (1992) The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix. In Herrington CS, McGee O, eds. Diagnostic molecular pathology: a practical approach. Oxford: Oxford University Press, pp. 152-172.Google Scholar
  25. 25.
    Ferlay J, Bray F, Pisani P, Parkin DM (2001) Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press.Google Scholar
  26. 26.
    Winkelstein Jr W, Shillitoe EJ, Brand R, Johnson KK (1984) Further comments on cancer of the uterine cervix, smoking, and herpesvirus infection. Am J Epidemiol 119: 1-8.Google Scholar
  27. 27.
    Winkelstein Jr W. (1990) Smoking and cervical cancer-current status: a review. Am J Epidemiol 131: 945-957.Google Scholar
  28. 28.
    Phillips AN, Smith GD (1994) Cigarette smoking as a potential cause of cervical cancer: has confounding been controlled? Int J Epidemiol 23: 42-49.Google Scholar
  29. 29.
    zur Hausen H (1976) Condylomata acuminata and human genital cancer. Cancer Res 36: 794.Google Scholar
  30. 30.
    Herrero R, Brinton LA, Reeves WC, et al. (1989) Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 81: 205-211.Google Scholar
  31. 31.
    Hakama M, Luostarinen T, Hallmans G, et al. (2000) Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control 11: 783-790.Google Scholar
  32. 32.
    Olsen AO, Dillner J, Skrondal A, Magnus P (1998) Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology 9: 346-349.Google Scholar
  33. 33.
    Ylitalo N, Sorensen P, Josefsson A, et al. (1999) Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 81: 357-365.Google Scholar
  34. 34.
    Becker TM, Wheeler CM, McGough NS, et al. (1994) Cigarette smoking and other risk factors for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 3: 113-119.Google Scholar
  35. 35.
    Kjellberg L, Hallmans G, Ahren AM, et al. (2000) Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 82: 1332-1338.Google Scholar
  36. 36.
    Deacon JM, Evans CD, Yule R, et al. (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 83: 1565-1572.Google Scholar
  37. 37.
    Hildesheim A, Herrero R, Castle PE, et al. (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84: 1219-1226.Google Scholar
  38. 38.
    Lacey Jr JV, Frisch M, Brinton LA, et al. (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12: 153-161.Google Scholar
  39. 39.
    Ho GY, Kadish AS, Burk RD, et al. (1998) HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 78: 281-285.Google Scholar
  40. 40.
    Szarewski A, Jarvis MJ, Sasieni P, et al. (1996) Effect of smoking cessation on cervical lesion size. Lancet 347: 941-943.Google Scholar
  41. 41.
    Rous P, Friedwald W (1944) The effect of chemical carcinogens on virus-induced rabbit papillomas. J Exp Med 79: 511-538.Google Scholar
  42. 42.
    Yang X, Jin G, Nakao Y, Rahimtula M, Pater MM, Pater A (1996) Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis. Int J Cancer 65: 338-344.Google Scholar
  43. 43.
    IARC (1986) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 38. Tobacco Smoking. Lyon: International Agency for Research on Cancer.Google Scholar
  44. 44.
    Szarewski A, Cuzick J (1998) Smoking and cervical neoplasia: a review of the evidence. J Epidemiol Biostatist 3: 229-256.Google Scholar
  45. 45.
    Simons AM, Mugica vH, Rodriguez JA, et al. (1995) Demonstration of smoking-related DNA damage in cervical epithelium and correlation with human papillomavirus type 16, using exfoliated cervical cells. Br J Cancer 71: 246-249.Google Scholar
  46. 46.
    Cerqueira EM, Santoro CL, Donozo NF, et al. (1998) Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol 42: 639-649.Google Scholar
  47. 47.
    Poppe WA, Ide PS, Drijkoningen MP, Lauweryns JM, Van Assche FA (1995) Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 39: 34-38.Google Scholar
  48. 48.
    IARC 2003. IARC Monographs on the Evaluation of Carcinogenic Risks to humans, Volume 83. Tobacco Smoke and Involuntary Smoking. Lyon, International Agency for Research on Cancer, (in press).Google Scholar
  49. 49.
    Dobson AJ, Kuulasmaa K, Moltchanov V, et al. (1998) Changes in cigarette smoking among adults in 35 populations in the mid-1980s. WHO MONICA Project. Tob Control 7: 14-21.Google Scholar
  50. 50.
    Ernster V, Kaufman N, Nichter M, Samet J, Yoon SY (2000) Women and tobacco: moving from policy to action. Bull World Health Organ 78: 891-901.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Martyn Plummer
    • 1
  • Rolando Herrero
    • 2
  • Silvia Franceschi
    • 1
  • Chris J.L.M. Meijer
    • 3
  • Peter Snijders
    • 3
  • F. Xavier Bosch
    • 4
  • Silvia de Sanjosé
    • 4
  • Nubia Muñoz
    • 1
  1. 1.International Agency for Research on CancerLyonFrance
  2. 2.Proyecto Epidemiologic GuanacasteCosta RicaThe Netherlands
  3. 3.VU Medical CenterDepartment of PathologyAmsterdamThe Netherlands
  4. 4.Epidemiology and Cancer Registry ServiceCatalan Institute of Oncology (ICO)BarcelonaSpain

Personalised recommendations